Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
Abstract Background Magnetic resonance spectroscopy (MRS) studies have identified elevated levels of the phospholipid precursor phosphocholine (PC) and phosphoethanolamine (PE) as metabolic hallmarks of cancer. Unusually, however, PC and PE levels are reduced in mutant isocitrate dehydrogenase 1 (ID...
Main Authors: | Pavithra Viswanath, Marina Radoul, Jose Luis Izquierdo-Garcia, Hema Artee Luchman, J. Gregory Cairncross, Russell O. Pieper, Joanna J. Phillips, Sabrina M. Ronen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Cancer & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40170-018-0178-3 |
Similar Items
-
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
by: Makoto Nakagawa, et al.
Published: (2022-06-01) -
Serum D‐2‐hydroxyglutarate and the ratio of D‐2HG/L‐2HG predict IDH mutation in acute myeloid leukemia
by: Chelsea Zhang, et al.
Published: (2023-08-01) -
Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma
by: Marina Radoul, et al.
Published: (2021-02-01) -
Molecular Imaging Of Metabolic Reprogramming In Mutant IDH Cells
by: Pavithra eViswanath, et al.
Published: (2016-03-01) -
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
by: Manabu Natsumeda, et al.
Published: (2021-11-01)